MRI Predicts Response to VEGF Inhibitor in Recurrent Glioblastoma MRI Predicts Response to VEGF Inhibitor in Recurrent Glioblastoma
Predicting the response to therapy comes down to contrast enhancing patterns on the pretreatment MRI, a new study suggests. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 23, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pembro+Chemo as First-Line Standard of Care for Esophageal Cancer Pembro+Chemo as First-Line Standard of Care for Esophageal Cancer
An additional 12 months of follow-up confirmed the benefits of the combination therapy as a first-line treatment for advanced or metastatic esophageal cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Some Young Cancer Survivors Still Paying Hefty Costs 20 Later Some Young Cancer Survivors Still Paying Hefty Costs 20 Later
Increased out-of-pocket medical expenses among young cancer survivors with persistent psychological distress highlight the need for better interventions.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 21, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Some Young Cancer Survivors Paying Hefty Costs 20 Years Later Some Young Cancer Survivors Paying Hefty Costs 20 Years Later
Increased out-of-pocket medical expenses among young cancer survivors with persistent psychological distress highlight the need for better interventions.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 20, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

' New Standard of Care' for HER2-Mutant NSCLC?'New Standard of Care' for HER2-Mutant NSCLC?
Patients with non –small cell lung cancer harboring HER2 mutations experienced durable activity and promising survival outcomes with trastuzumab deruxtecan, a new study shows.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Siblings of People With Bipolar Disorder Have Higher Cancer Risk Siblings of People With Bipolar Disorder Have Higher Cancer Risk
Findings from Taiwan suggest an increased cancer risk not only for people with bipolar disorder but for their unaffected siblings too.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Overdiagnosis, Misleading 5-Year Lung Cancer Survival in Taiwan Overdiagnosis, Misleading 5-Year Lung Cancer Survival in Taiwan
A push to increase lung cancer screening among a largely nonsmoking Asian female population led to significant overdiagnosis and dubiously high 5-year survival rates, researchers in Taiwan report.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Could Probiotics Reduce'Chemo Brain' in Breast Cancer Patients? Could Probiotics Reduce'Chemo Brain' in Breast Cancer Patients?
Patients with breast cancer reported fewer symptoms of cognitive impairment associated with chemotherapy when they took a probiotics supplements, reports the first study of its kind.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Unnecessary Use of Radiotherapy Persists in End-of-life Patients Unnecessary Use of Radiotherapy Persists in End-of-life Patients
The use of unnecessary radiotherapy in metastatic cancer patients near the end of life is still higher than guidelines recommend, suggesting the need for better adherence to the guidelines.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 17, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Extensive Informed Consent May Not Improve Patients' Understanding of Their Cancer Care Extensive Informed Consent May Not Improve Patients' Understanding of Their Cancer Care
Providing detailed informed consent does not appear to improve patients ' comprehension, according to a study published on researchsquare.com as a preprint.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 16, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

MRI Could Replace CT for Detecting Metastatic Testicular Cancer MRI Could Replace CT for Detecting Metastatic Testicular Cancer
This study, published on researchsquare.com as a preprint and not yet peer reviewed, found no meaningful loss of sensitivity with MRI compared with CT, and eliminates radiation exposure.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Radiation Oncology: More Women Now, but Numbers Still Low Radiation Oncology: More Women Now, but Numbers Still Low
Although recent years have seen more women, minorities remain particularly underrepresented in senior faculty positions in radiation oncology.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 14, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pancreatic Cancer Test Validated for Newly Diagnosed Diabetes Pancreatic Cancer Test Validated for Newly Diagnosed Diabetes
Researchers derived and validated a proprietary screening test to detect pancreatic cancer in people with new-onset diabetes. The test uses an epigenetic analysis of a 20 mL blood specimen.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 13, 2022 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

HPV Vaccines Could Shift Rates of Many Cancers, Not Only Cervical HPV Vaccines Could Shift Rates of Many Cancers, Not Only Cervical
The impressive data on how HPV vaccination has cut cervical cancer rates tells only part of the story of how many other lives could be transformed.WebMD Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 13, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Uterine Cancer Patients Are Step Closer to 9/11 Benefits Uterine Cancer Patients Are Step Closer to 9/11 Benefits
The World Trade Center Health Program is considering covering the most common form of uterine cancer, in what patient advocates say is a key acknowledgment of the women affected by the 9/11 fallout.Kaiser Health News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 13, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news